{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:33:33Z","timestamp":1773876813276,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,4]]},"DOI":"10.1093\/nar\/gkx1018","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T15:11:44Z","timestamp":1508253104000},"page":"D1144-D1149","source":"Crossref","is-referenced-by-count":217,"title":["TumorFusions: an integrative resource for cancer-associated transcript fusions"],"prefix":"10.1093","volume":"46","author":[{"given":"Xin","family":"Hu","sequence":"first","affiliation":[]},{"given":"Qianghu","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Ming","family":"Tang","sequence":"additional","affiliation":[]},{"given":"Floris","family":"Barthel","sequence":"additional","affiliation":[]},{"given":"Samirkumar","family":"Amin","sequence":"additional","affiliation":[]},{"given":"Kosuke","family":"Yoshihara","sequence":"additional","affiliation":[]},{"given":"Frederick M","family":"Lang","sequence":"additional","affiliation":[]},{"given":"Emmanuel","family":"Martinez-Ledesma","sequence":"additional","affiliation":[]},{"given":"Soo Hyun","family":"Lee","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1031-9424","authenticated-orcid":false,"given":"Siyuan","family":"Zheng","sequence":"additional","affiliation":[]},{"given":"Roel G W","family":"Verhaak","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"key\n\t\t\t\t20180103185616_B1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc3947","article-title":"The emerging complexity of gene fusions in cancer","volume":"15","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20180103185616_B2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.1220834","article-title":"Transforming fusions of FGFR and TACC genes in human glioblastoma","volume":"337","year":"2012","journal-title":"Science"},{"key":"key\n\t\t\t\t20180103185616_B3","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/0008-5472.CAN-16-3563","article-title":"A systematic analysis of oncogenic gene fusions in primary colon cancer","volume":"77","year":"2017","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20180103185616_B4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1249484","article-title":"Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma","volume":"343","year":"2014","journal-title":"Science"},{"key":"key\n\t\t\t\t20180103185616_B5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","year":"2005","journal-title":"Science"},{"key":"key\n\t\t\t\t20180103185616_B6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma","volume":"29","year":"2016","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20180103185616_B7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma","volume":"31","year":"2017","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20180103185616_B8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Cancer Genome Atlas Research Network. Electronic address, w.b.e and Cancer Genome Atlas Research, N.","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180103185616_B9","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1038\/ncomms5846","article-title":"The landscape of kinase fusions in cancer","volume":"5","year":"2014","journal-title":"Nat. Commun."},{"key":"key\n\t\t\t\t20180103185616_B10","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1038\/onc.2014.406","article-title":"The landscape and therapeutic relevance of cancer-associated transcript fusions","volume":"34","year":"2015","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180103185616_B11","first-page":"D784","article-title":"ChimerDB 3.0: an enhanced database for fusion genes from cancer transcriptome and literature data mining","volume":"45","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185616_B12","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/bioinformatics\/btu169","article-title":"PRADA: pipeline for RNA sequencing data analysis","volume":"30","year":"2014","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180103185616_B13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc2091","article-title":"The impact of translocations and gene fusions on cancer causation","volume":"7","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20180103185616_B14","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world's knowledge of somatic mutations in human cancer","volume":"43","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185616_B15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nmeth.3505","article-title":"SpeedSeq: ultra-fast personal genome analysis and interpretation","volume":"12","year":"2015","journal-title":"Nat. Methods"},{"key":"key\n\t\t\t\t20180103185616_B16","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/bioinformatics\/btt131","article-title":"Identification of cancer fusion drivers using network fusion centrality","volume":"29","year":"2013","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180103185616_B17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng1416","article-title":"Detection of large-scale variation in the human genome","volume":"36","year":"2004","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20180103185616_B18","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ymthe.2005.09.006","article-title":"Spliceosome-mediated RNA trans-splicing","volume":"12","year":"2005","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20180103185616_B19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrg3767","article-title":"Expanding the computational toolbox for mining cancer genomes","volume":"15","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"key\n\t\t\t\t20180103185616_B20","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human Protein Reference Database\u20132009 update","volume":"37","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185616_B21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-3-319-17121-0_35","article-title":"A comprehensive review of mutations in the MERTK proto-oncogene","volume":"854","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"key\n\t\t\t\t20180103185616_B22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1126\/science.356.6343.1111","article-title":"In a major shift, cancer drugs go \u2018tissue-agnostic\u2019","volume":"356","year":"2017","journal-title":"Science"},{"key":"key\n\t\t\t\t20180103185616_B23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ijc.29825","article-title":"The distribution of BRAF gene fusions in solid tumors and response to targeted therapy","volume":"138","year":"2016","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20180103185616_B24","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/nm.4204","article-title":"Recurrent MET fusion genes represent a drug target in pediatric glioblastoma","volume":"22","author":"International Cancer Genome Consortium PedBrain Tumor, P.","year":"2016","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20180103185616_B25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","article-title":"Safety and antitumor activity of the multitargeted Pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1)","volume":"7","year":"2017","journal-title":"Cancer Discov."},{"key":"key\n\t\t\t\t20180103185616_B26","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1101\/gad.213686.113","article-title":"A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival","volume":"27","year":"2013","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20180103185616_B27","first-page":"1215","article-title":"EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1\/2","volume":"384","year":"2003","journal-title":"Biol. Chem."},{"key":"key\n\t\t\t\t20180103185616_B28","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1158\/0008-5472.CAN-16-2745","article-title":"Engineering and functional characterization of fusion genes identifies novel oncogenic drivers of cancer","volume":"77","year":"2017","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20180103185616_B29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2014.59.8433","article-title":"Basket trials and the evolution of clinical trial design in an era of genomic medicine","volume":"33","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20180103185616_B30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng.3781","article-title":"Systematic analysis of telomere length and somatic alterations in 31 cancer types","volume":"49","year":"2017","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20180103185616_B31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180103185616_B32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A comprehensive transcriptional portrait of human cancer cell lines","volume":"33","year":"2015","journal-title":"Nat. Biotechnol."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/46\/D1\/D1144\/23161976\/gkx1018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T16:32:20Z","timestamp":1570206740000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/nar\/article\/46\/D1\/D1144\/4584571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":32,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2017,11,1]]},"published-print":{"date-parts":[[2018,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkx1018","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/162180","asserted-by":"object"}]},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1,4]]},"published":{"date-parts":[[2017,11,1]]}}}